The temperature-sensitive and attenuation phenotypes of the poliovirus type 3 vaccine strain are largely determined by a specific mutation in the VP3 capsid protein that causes an early assembly defect.
Answers are grounded in this paper and cite their sources.
May inform poliovirus vaccine attenuation strategies; leaves open translation from animal models to humans.
The molecular basis of the temperature-sensitive (ts) phenotype of P3/Sabin, the type 3 vaccine strain of poliovirus, was investigated in light of the known correlation between ts and attenuation phenotypes. A phenylalanine at residue 91 of the capsid protein VP3 was a major determinant of both phenotypes, and attenuation and ts could be reverted by the same second-site mutations. The ts phenotype was due to a defect early in the assembly process that inhibited the formation of 14S pentamers, empty capsids, and virions. It was further shown that capsid proteins that were not incorporated into higher-order structures had short half-lives at the nonpermissive temperature.
No takes yet. Share an insight, caveat, or question.
Macadam et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: